Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by 123ABC on Feb 24, 2021 7:29am

Fully Diluted

So how many shares fully diluted are we looking at now? 60-70 million?
Comment by MrMugsy on Feb 24, 2021 7:57am
I believe the number is approx. 58M I will now use 65M for calculations Imo
Comment by Forestview on Feb 24, 2021 8:28am
I'm with you Mugs, but I'm using 70M.  Better to be (more) conservative.  So, money hits our account today.  Should be a good day.  Fingers crossed. Let's end Feb with a bang.   
Comment by MrMugsy on Feb 24, 2021 10:12am
Ya - I'll be using 70M before you know it. I've been using 60,000,000 for over a year now. : )
Comment by Doccole on Feb 24, 2021 10:30am
70m at 2b evaluation- looking at 30 dollar stock. is that fair?
Comment by antibeast on Feb 24, 2021 10:54am
Is that just for one drug? The 2b eval
Comment by Doccole on Feb 24, 2021 11:39am
Yes, until we get others in phase 1
Comment by 3burtc on Feb 24, 2021 10:35am
Oh oh oh....... I'm guessing a chicken burger WITH fries. If they have to go as far as a fully roasted chicken with mashed potatoes and gravy, I can live with that.
Comment by WalkOverTheStrt on Feb 24, 2021 8:34am
thoughts on further dilution with holding co? May add another 10-15m shares imo...
Comment by Forestview on Feb 24, 2021 9:12am
WOTS I'd like to think the 70M includes the dilution, which I said would be about 16M.  But, I could be wrong.  
Comment by CalgaryATE on Feb 24, 2021 10:58am
56 million (currently) Feb. 12, 2021 - Financials - Total Share count as of Dec. 31, 2020: - common shares:  38,779,772 - options:  1,228,035 - RSUs:  1,681,491 - warrants:  4,226,590   Total on Dec. 31, 2020:  45,915,888 Feb. deal:  5,850,000 * 1.15 -->  6,727,500 units   -->  6,727,500 shares + 3,363,750 warrants ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities